Theradaptive is revolutionizing the field of therapeutic delivery with a pipeline of first-in-class and best-in-class products that address an $80B global market. We are pursuing previously out-of-reach clinical indications in vascular, soft tissue, and orthopedic repair as well as targeted chemotherapeutics.